We have demonstrated the effect of galectin-9 in various gastroenterological cancers, such as esophageal cancer [17], hepatocellular carcinoma [18], cholangiocarcinoma [19], and pancreatic cancer [20]. The gene discussed is LGALS9; the disease is pancreatic neoplasm.